J.P.H. van Wijk

977 total citations
24 papers, 750 citations indexed

About

J.P.H. van Wijk is a scholar working on Endocrinology, Diabetes and Metabolism, Emergency Medicine and Molecular Biology. According to data from OpenAlex, J.P.H. van Wijk has authored 24 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Emergency Medicine and 6 papers in Molecular Biology. Recurrent topics in J.P.H. van Wijk's work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), HIV-related health complications and treatments (7 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). J.P.H. van Wijk is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), HIV-related health complications and treatments (7 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). J.P.H. van Wijk collaborates with scholars based in Netherlands, Spain and United States. J.P.H. van Wijk's co-authors include Manuel Castro Cabezas, Ton J. Rabelink, Eelco J.P. de Koning, Edwin P. Martens, Jorge Joven, Jos Op ’t Roodt, Constantijn J.M. Halkes, Andy I. M. Hoepelman, D.W. Erkelens and Andy M. Hoepelman and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

J.P.H. van Wijk

24 papers receiving 722 citations

Peers

J.P.H. van Wijk
Elena Korsheninnikova Finland
Montse Guardiola Spain
Hootan Khatami United States
Frank D. Seney United States
Kunhua Wang China
Majnu John United States
Eli A. Friedman United States
Nuzhet O. Atuk United States
Maurizio Soldini Italy
J. Otvos United States
Elena Korsheninnikova Finland
J.P.H. van Wijk
Citations per year, relative to J.P.H. van Wijk J.P.H. van Wijk (= 1×) peers Elena Korsheninnikova

Countries citing papers authored by J.P.H. van Wijk

Since Specialization
Citations

This map shows the geographic impact of J.P.H. van Wijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P.H. van Wijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P.H. van Wijk more than expected).

Fields of papers citing papers by J.P.H. van Wijk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P.H. van Wijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P.H. van Wijk. The network helps show where J.P.H. van Wijk may publish in the future.

Co-authorship network of co-authors of J.P.H. van Wijk

This figure shows the co-authorship network connecting the top 25 collaborators of J.P.H. van Wijk. A scholar is included among the top collaborators of J.P.H. van Wijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P.H. van Wijk. J.P.H. van Wijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bon, Arianne C. van, Gozewijn D. Laverman, A. H. L. Mulder, et al.. (2024). Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands. The Lancet Digital Health. 6(4). e272–e280. 13 indexed citations
2.
Wijk, J.P.H. van, et al.. (2012). Scintigraphic Detection of Benign Ovarian Teratoma after Total Thyroidectomy and Radioactive Iodine for Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1094–1095. 13 indexed citations
3.
Wijk, J.P.H. van & E.W.M.T. ter Braak. (2011). Amenorrhea, Abdominal Pain, and Weight Gain. New England Journal of Medicine. 365(19). e39–e39. 2 indexed citations
4.
Klop, Boudewijn, Jeffrey S. Cohn, A.J.H.H.M. van Oostrom, et al.. (2011). Daytime triglyceride variability in men and women with different levels of triglyceridemia. Clinica Chimica Acta. 412(23-24). 2183–2189. 14 indexed citations
5.
Wijk, J.P.H. van, Koen M.A. Dreijerink, Carolina R C Pieterman, et al.. (2011). Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers. Clinical Endocrinology. 76(1). 67–71. 18 indexed citations
6.
Wijk, J.P.H. van & Manuel Castro Cabezas. (2011). Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. International Journal of Vascular Medicine. 2012. 1–13. 53 indexed citations
7.
Wijk, J.P.H. van, Andy I. M. Hoepelman, Eelco J.P. de Koning, et al.. (2010). Differential Effects of Rosiglitazone and Metformin on Postprandial Lipemia in Patients With HIV-Lipodystrophy. Arteriosclerosis Thrombosis and Vascular Biology. 31(1). 228–233. 14 indexed citations
8.
Alipour, Arash, A.J.H.H.M. van Oostrom, J.P.H. van Wijk, et al.. (2009). Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects. Atherosclerosis. 206(2). 444–450. 13 indexed citations
9.
Coll, Blai, J.P.H. van Wijk, Sandra Parra, et al.. (2006). Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. European Journal of Pharmacology. 544(1-3). 104–110. 35 indexed citations
10.
Wijk, J.P.H. van, Eelco J.P. de Koning, Manuel Castro Cabezas, et al.. (2006). Functional and Structural Markers of Atherosclerosis in Human Immunodeficiency Virus-Infected Patients. Journal of the American College of Cardiology. 47(6). 1117–1123. 89 indexed citations
11.
Wijk, J.P.H. van & Ton J. Rabelink. (2005). Impact of thiazolidinedione therapy on atherogenesis. Current Atherosclerosis Reports. 7(5). 369–374. 13 indexed citations
12.
Wijk, J.P.H. van, Manuel Castro Cabezas, Eelco J.P. de Koning, et al.. (2005). In VivoEvidence of Impaired Peripheral Fatty Acid Trapping in Patients with Human Immunodeficiency Virus-Associated Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3575–3582. 22 indexed citations
13.
Wijk, J.P.H. van, Manuel Castro Cabezas, Blai Coll, et al.. (2005). Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes. Atherosclerosis. 186(1). 152–159. 21 indexed citations
14.
Westerweel, Peter E., J.P.H. van Wijk, & Marianne C. Verhaar. (2005). [The polypill: not an effective strategy for reduction of cardiovascular disease].. PubMed. 149(31). 1741–1741. 2 indexed citations
15.
Wijk, J.P.H. van, Eelco J.P. de Koning, Jos Op ’t Roodt, et al.. (2005). Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy. Annals of Internal Medicine. 143(5). 337–346. 2 indexed citations
16.
17.
Wijk, J.P.H. van, Constantijn J.M. Halkes, D.W. Erkelens, & Manuel Castro Cabezas. (2003). Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism. 52(8). 1043–1049. 52 indexed citations
18.
Halkes, Constantijn J.M., J.P.H. van Wijk, Josep Ribalta, L. Masana, & Manuel Castro Cabezas. (2003). Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids. Journal of Internal Medicine. 255(1). 74–81. 13 indexed citations
19.
Wijk, J.P.H. van, Eelco J.P. de Koning, Edwin P. Martens, & Ton J. Rabelink. (2003). Thiazolidinediones and Blood Lipids in Type 2 Diabetes. Arteriosclerosis Thrombosis and Vascular Biology. 23(10). 1744–1749. 142 indexed citations
20.
Halkes, Constantijn J.M., M. Castro Cabezas, J.P.H. van Wijk, & D.W. Erkelens. (2000). Obesity overrules the beneficial gender efects on triglyceride metabolism in non-obese subjects. Atherosclerosis. 151(1). 97–97. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Korsheninnikova Breakdown of academic impact, for papers by Montse Guardiola Breakdown of academic impact, for papers by Hootan Khatami Breakdown of academic impact, for papers by Frank D. Seney Breakdown of academic impact, for papers by Kunhua Wang Breakdown of academic impact, for papers by Majnu John Breakdown of academic impact, for papers by Eli A. Friedman Breakdown of academic impact, for papers by Nuzhet O. Atuk Breakdown of academic impact, for papers by Maurizio Soldini Breakdown of academic impact, for papers by J. Otvos
Rankless by CCL
2026